1401.1 The Advisory Committee shall convene as needed to monitor best practices in other states, monitor scientific research on the use of medical cannabis, monitor the effectiveness of the District's medical cannabis program, the adequacy of the medical cannabis supply in the District of Columbia, and make recommendations to the Mayor, the Council, the Board, or consult with other agencies.

1401.2 The Committee shall conduct a fair and impartial proceeding, assure that the facts are fully elicited, and avoid delay. The chairperson shall have authority to take all measures necessary for the maintenance of order and for the efficient, fair and impartial resolution of issues that arise during public hearing proceedings or any public meeting in which a quorum of the Committee are present.

SOURCE: Final Rulemaking published at 60 DCR 10061 (July 12, 2013); as amended by Final Rulemaking published at 71 DCR 002388 (March 8, 2024); as amended by Final Rulemaking published at 73 DCR 002136 (February 20, 2026).